ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 18.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $73,000 | -27.0% | 48,615 | -51.7% | 0.00% | – |
| Q2 2022 | $100,000 | +25.0% | 100,644 | +637.3% | 0.00% | – |
| Q3 2021 | $80,000 | -32.2% | 13,650 | -6.5% | 0.00% | – |
| Q2 2021 | $118,000 | -15.1% | 14,600 | -12.6% | 0.00% | – |
| Q1 2021 | $139,000 | -73.8% | 16,700 | -76.1% | 0.00% | – |
| Q4 2020 | $530,000 | -59.4% | 69,892 | -18.9% | 0.00% | -100.0% |
| Q2 2020 | $1,306,000 | -6.2% | 86,179 | +30.1% | 0.00% | -50.0% |
| Q1 2019 | $1,392,000 | +92.5% | 66,264 | +5.4% | 0.00% | 0.0% |
| Q4 2018 | $723,000 | -81.4% | 62,898 | -57.5% | 0.00% | -81.8% |
| Q4 2017 | $3,881,000 | +89.0% | 148,135 | +62.0% | 0.01% | +57.1% |
| Q3 2017 | $2,053,000 | -34.2% | 91,446 | -23.8% | 0.01% | -82.5% |
| Q2 2014 | $3,121,000 | +755.1% | 120,038 | +616.7% | 0.04% | +900.0% |
| Q1 2014 | $365,000 | – | 16,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,213,326 | $18,386,000 | 10.92% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,776,121 | $31,417,000 | 4.70% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,358,644 | $11,304,000 | 1.44% |
| Selkirk Management LLC | 288,805 | $2,403,000 | 0.72% |
| Chicago Capital, LLC | 1,593,126 | $13,255,000 | 0.56% |
| Cannell & Co. | 1,097,419 | $9,131,000 | 0.29% |
| TCI Wealth Advisors, Inc. | 55,586 | $462,000 | 0.20% |
| Belpointe Asset Management LLC | 197,853 | $1,646,000 | 0.14% |
| ALGERT GLOBAL LLC | 29,580 | $246,000 | 0.08% |
| THOMPSON INVESTMENT MANAGEMENT, INC. | 60,900 | $507,000 | 0.08% |